Johnson & Johnson to Participate in the Leerink Global Biopharma Conference

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will participate in the Leerink Global Biopharma Conference on Tuesday, March 12th, at the Fontainebleau Miami Beach, FL. Joe Wolk, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240212450230/en/

Media contact:
[email protected]

Investor contact:
[email protected]

Source: Johnson & Johnson

You May Also Be Interested In

• UAE Opens 15th UN Congress on Crime Prevention and Criminal Justice and Launches Pledge4Justice with First Pledge of Up to USD 5 Million
• Pi Network Price Prediction: 30M Users Still Can’t Fix PI’s Price as AlphaPepe Builds Momentum With 12,000+ Holders
• Best Crypto To Invest In: AlphaPepe Passes $2.8M as Binance Listing Rumours Build Before the 5th CEX Reveal